Great Pacific Capital

Great Pacific Capital is a private investment and holding company that serves as a primary investment vehicle for the Jim Pattison Group, one of Canada's largest privately held conglomerates. While the firm maintains a diversified portfolio across sectors such as forestry, media, and food services, it is a significant player in the life sciences sector through strategic equity positions in biotechnology companies. Most notably, Great Pacific Capital is a major shareholder in Aptose Biosciences, a clinical-stage company developing targeted therapies for oncology. The firm focuses on long-term value creation by providing capital and strategic oversight to its portfolio companies rather than engaging in direct drug discovery or development.